ArticleEuropean radiology2024

Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST.

Ying Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.